Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 49 - Preparations for testing in vivo
Patents for A61K 49 - Preparations for testing in vivo (35,376)
10/2008
10/30/2008US20080267883 Comprises carboxyl or carbonyl functionalized pyridine moiety; bioconjugation; biocompatability; in vivo optical imaging
10/30/2008US20080267882 Multimeric RGD (arginine-glycine-aspartic acid (Arg-Gly-Asp)) peptide; positron emission tomography; angiogenesis; kits
10/30/2008US20080267881 Peptide-based compounds for use as targeting vectors that bind to receptors associated with angiogenesis; may thus be used for diagnosis or therapy of, for example, malignant diseases, heart diseases, endometriosis, inflammation-related diseases, rheumatoid arthritis and Kaposi's s sarcoma
10/30/2008US20080267880 Via uptake of fluorescent marker dye on microtiter plates; kits
10/30/2008US20080267878 Targeted Imaging And/Or Therapy Using The [3+2] Azide-Alkyne Cycloaddition
10/30/2008US20080267877 Administering carrier molecule such as albumin conjugated to mannose-6-phosphate; particularly targeting Hepatic Stellate Cells (HSC); glomeruloscherosis, interstitial fibrosis, lung fibrosis, atherosclerosis, Crohn's disease, colitis ulcerosa, glomerulonephritis and sepsis; diagnosis
10/30/2008US20080267876 Nanoparticles for Targeted Delivery of Active Agent
10/30/2008US20080267875 Androgens conjugated with mammalian proteins; diagnosis or treatment of solid cancer and hematological malignancies; exhibit synergistic action together with a cytoskeleton-acting drug; prostate cancer
10/30/2008US20080267874 Targeted Neuronal And Glial Human Embryonic Stem Cell Line
10/30/2008US20080267873 Aqueous injection buffer containing sodium chloride, calcium chloride, potassium chloride in the preparation of a RNA injection solution for increasing RNA transfer, RNA translation in a host organism
10/30/2008US20080267872 The 98P4B6 gene, its fragment, its encoded protein, variants , or a fragment, can be used to elicit a humoral or cellular immune response; antibodies or T cells reactive with 98P4B6 can be used in active or passive immunization
10/30/2008US20080267871 Cardioinhibitory/ Antihypertensive Novel Endogenous Physiologically Active Peptide
10/30/2008US20080267863 Method of Diagnosing, Monitoring, Staging, Imaging and Treating Colon Cancer
10/29/2008EP1985312A1 T1 reduction in 19F magnetic resonance imaging (MRI)
10/29/2008EP1984929A1 Preparation of poly(ethylene oxide)-coated nanoparticles of maghemite
10/29/2008EP1984029A2 Methods of identifying and treating patients likely to benefit from omega-3 fatty acid therapy for dementia, vascular dementia, parkinson's dementia, alzheimer's disease, and/or mild cognitive impairment
10/29/2008EP1983973A1 Oral dtpa for radionuclide chelation
10/29/2008EP1749026A4 Labelled adrenomedullin derivatives and their use for imaging and therapy
10/29/2008EP1629281B1 Diagnostic method for atherosclerosis
10/29/2008EP1553984B1 Use of a dye for colouring the lens capsuke or for colouring epiretinal membranes in the eye
10/29/2008EP1492776B1 Iodinated triglyceride analogs
10/29/2008EP1483399B1 Measurement of biosynthesis and breakdown rates of biological molecules that are inaccessible or not easily accessible to direct sampling, non-invasively, by label incorporation into metabolic derivatives and catabolitic products
10/29/2008CN101296927A Biocompatible N, N-disubstituted sulfonamide-containing fluorescent dye labels
10/29/2008CN101293878A Benzothiazole amino benzenes compounds, preparation method and application thereof
10/28/2008US7442558 Phthalamide-lanthanide complexes for use as luminescent markers
10/23/2008WO2008128051A2 Fluorescent nanoparticle compositions, methods and devices
10/23/2008WO2008127813A1 Hibernation-related genes and proteins, activators and inhibitors thereof and methods of use
10/23/2008WO2008127031A1 Magnetic resonance imaging contrast agents comprising zinc-containing magnetic metal oxide nanoparticles
10/23/2008WO2008126693A1 Remedy and diagnostic for mitochondrial dysfunction brain disease
10/23/2008WO2008125422A2 Use of metal nanoparticles for diagnosing alzheimer disease
10/23/2008WO2008076784A3 Methods and compositions for treating il-4 or il-13 related fibrosis related pathologies
10/23/2008WO2008073292A3 Method for protecting renal tubular epithelial cells from radiocontrast nephro parhy (rcn)
10/23/2008WO2008046038A3 Intranasal therapeutics for neuroprotection
10/23/2008WO2007108829A3 Tuberculosis nucleic acids, polypeptides and immunogenic compositions
10/23/2008WO2006135799A3 Detection of hookworm coproantigens
10/23/2008US20080263686 Animal model for pigment spots
10/23/2008US20080263685 Transgenic non-human animal expressing metabotropic glutamate receptor 1 in a melanocyte-specific manner for identifying modulators for prevention and treatment of cell proliferative disorders
10/23/2008US20080261960 Photosensitizers for photodynamic therapy; killing tissue, cells; anticancer agents
10/23/2008US20080260839 Stable, high porosity silicon microparticle aerosol carriers derived from semiconductor p+ wafers; resorbable and/or photoluminescent
10/23/2008US20080260759 Novel Mite Allergen
10/23/2008US20080260753 Transgenic animal model expressing NOD mutant for use in identifying modulator for treatment of inflammatory bowel disease
10/23/2008US20080260652 Composition for dyeing dental plaque for evaluating dental caries activity
10/23/2008US20080260651 Contrast agents
10/23/2008US20080260650 Administering diagnostic agent and immunology moderator; detecting inflammed tissue
10/23/2008US20080260649 Using mixture of trityl compound and paramagnetic compound
10/23/2008US20080260648 Pharmaceutical Preparation Containing Magnetic Vesicular Particles, Manufacturing Method Thereof and Diagnostic Therapeutic System
10/23/2008US20080260646 Imaging Reporters of Transgene Expression
10/23/2008US20080260644 Adjust concentration of chloride channel moderators within brain
10/23/2008US20080260642 Fusion protein mixture containing bacteriophage specific protein and ligand; detection of target structures; peptide binding signal generating material
10/23/2008US20080260641 Isolated human monoclonal antibodies which bind to lymphocyte function associated antigens; therapy and diagnosis methods; skin disorders; antiarthritic agents; inflammatory bowel disease
10/23/2008US20080260640 Use of Precursors Of Tachykinins and/or Their Fragments in Medical Diagnostic
10/23/2008US20080260634 Administering with imaging agent; imaging tissue of mammal, human; diagnosis of cancer
10/23/2008CA2683635A1 Fluorescent nanoparticle compositions, methods, and devices
10/23/2008CA2682855A1 Therapeutic agent and diagnostic agent for mitochondrial dysfunction brain diseases
10/22/2008EP1982733A1 Use of a contrast agent for magnetic resonance imaging of endoleaks
10/22/2008EP1982188A2 Method to determine and biomarker for treatment efficacy with ssri, snri, and sari antidepressants
10/22/2008EP1981503A2 Novel neurological function of mpkci
10/22/2008EP1856521A4 Modulation of th2 lineage commitment by t-bet
10/22/2008EP1605979B1 Conjugates for medical imaging comprising carrier, targeting moiety and a contrast agent
10/22/2008EP1235861B1 Transgenic mouse expressing steroid-activated nuclear receptor
10/22/2008CN101289665A Process for establishing anti-parkinson animal model
10/22/2008CN101289460A Organoboronic acid compounds and applications thereof as fluorescent probe
10/22/2008CN101288775A Capsules for intestine gasgraphy CT detection
10/22/2008CN101288774A Construction method of mice infection model of Suis Eperythrozoonsis
10/22/2008CN101288602A Method for establishing radiation induced vitiligo mice model and application thereof
10/22/2008CN100427142C Assistant for high-intensity focusing ultrasonic therapy and its screening method
10/21/2008US7439415 Population of Hoxb8 mutants and uses in identifying agents for treating repetitive behaviors
10/21/2008US7439324 amyotrophic lateral sclerosis-specific epitope is conjugated to keyhole limpet hemocyanin; biodrug for eliciting immune response in animal to produce antibody; use in diagnosis, prognosis and therapeutic intervention in neurodegenerative Alzheimer's disease, Parkinson's disease, Huntington's disease
10/21/2008US7439319 Selective substrates for matrix metalloproteinases
10/21/2008US7439268 Compositions containing prodrugs of florfenicol and methods of use
10/21/2008US7438908 Antitumor agents
10/21/2008US7438894 Polyhydroxy-polysulphonyl-glucose-benz(e)indoles; absorb and fluoresce in visible region; optical diagnosis of renal and cardiac diseases; tomography; magnetic resonance imaging
10/21/2008US7438893 Polybiotin compounds for magnetic resonance imaging and drug delivery
10/21/2008US7438892 Method of identifying inhibitors of GADD45 polypeptide activity, and inhibitors of such activity
10/21/2008US7438890 Binding peptides for carcinoembryonic antigen (CEA)
10/21/2008CA2146707C Substituted n-heteroaroylguanidines as inhibitors of na+/h+ exchange
10/21/2008CA2042064C C-erbb-2 external domain:gp75
10/16/2008WO2008124735A2 Multi-functional polyglutamate drug carriers
10/16/2008WO2008124640A1 Fluorescent light tomography
10/16/2008WO2008124483A1 Protein cage immunotherapeutics
10/16/2008WO2008123779A1 Trisubstituted triazamacrocycli c compounds and their use as contrast agents
10/16/2008WO2008089438A3 A membrane receptor for retinol binding protein mediates cellular uptake of vitamin a, methods of use and compositions
10/16/2008WO2008089394A3 Mycobacterium tuberculosis persistance genes
10/16/2008WO2008055059A3 Bi-functional peptides for multiple sclerosis treatment and diagnosis
10/16/2008WO2008023305A3 Contrast agent comprising a tm2+ containing luminescent substance for optical imaging
10/16/2008WO2008021234A3 Methods and compositions for needleless delivery of particles
10/16/2008WO2007134166A3 Real-time detection of influenza virus
10/16/2008WO2007123777A3 Inhibition of hif-1 activation for anti-tumor and anti-inflammatory responses
10/16/2008WO2007120911A3 Cellular labeling and quantification for nuclear magnetic resonance techniques
10/16/2008WO2007106577A3 Gelsolin in the treatment and diagnosis of neurological disease
10/16/2008WO2007056159A3 Hydrazone derivatives and uses thereof
10/16/2008WO2003038395A3 Remote nmr/mri detection of laser polarized gases
10/16/2008US20080254103 Wound Dressings Comprising a Protein Polymer and a Polyfunctional Spacer
10/16/2008US20080253975 Composition for dyeing dental plaque for evaluating dental caries activity
10/16/2008US20080253969 Multi-functional polyglutamate drug carriers
10/16/2008US20080253968 In vivo examination method
10/16/2008US20080253967 Halo-Stilbene Derivatives And Their Use For Binding And Imaging Of Amyloid Plaques
10/16/2008US20080253966 Diagnostic, Prognostic, and Therapeutic Factor Smac/Diablo in Human Cancer
10/16/2008US20080253960 Cell surface receptor ligand is covalently bonded to apoprotein; photodynamic therapy; antiglaucoma agents
10/15/2008EP1979004A2 Conjugates of semaphorin peptides as imaging agents for cancer
1 ... 117 118 119 120 121 122 123 124 125 126 127 128 129 130 131 132 133 134 135 136 137 ... 354